|
|
 |
|
LLY: Eli Lilly & Co - Stock News |
Enter Ticker:
|
|
| Nov 21, 2009 |
Aegis Rolls out Latest Version of Discoverant |
| Nov 21, 2009 |
AstraZeneca Seeks FDA Approval |
| Nov 20, 2009 |
Analyst Choice Initiates Market Analysis on Healthcare, Technologyand Consumer Goods Sectors |
| Nov 20, 2009 |
Trading Review for Vivus Inc. Issued by Beacon Equity |
| Nov 18, 2009 |
New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI |
| Nov 17, 2009 |
Growing Cross-Industry Demand for HPC and Cloud Computing Fuels CycleComputing's Rapid Expansion |
| Nov 16, 2009 |
Aegis Releases Discoverant 3.4 Enterprise Manufacturing Intelligence Software |
| Nov 16, 2009 |
Lilly Surpasses United Way 2009 Campaign Goal |
| Nov 15, 2009 |
Efient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease |
| Nov 15, 2009 |
Effient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease |
| Nov 13, 2009 |
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor |
| Nov 13, 2009 |
Eli Lilly Announced Paul Will Retire (LLY) |
| Nov 13, 2009 |
Fitch Revises Eli Lilly & Co.'s Outlook to Negative |
| Nov 13, 2009 |
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor |
| Nov 13, 2009 |
Cornerstone Therapeutics Appoints General Counsel |
| |
| ZACKS COMMENTARY FOR LLY |
| Nov 20, 2009 | Zacks Blog: AstraZeneca Seeks FDA Approval | | Nov 17, 2009 | Zacks Equity Research: Report for LLY | | Nov 16, 2009 | Zacks Blog: Bristol Divests Nutritional Segment | | Nov 10, 2009 | Industry Outlook: Big Pharma & Biotech | | Nov 10, 2009 | Zacks Analyst Interviews: Big Pharma & Biotech | | Nov 09, 2009 | Zacks Blog: Big Pharma and Biotech | | Oct 23, 2009 | Zacks Blog: Isis Diabetes Drug Shows Promise | | Oct 22, 2009 | Zacks Blog: Bristol-Myers Beats by a Penny | | Oct 22, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Eli Lilly & Co., Wells Fargo, Bank of America Corporation, Citigroup, Inc. and JPMorgan Chase & Co. | | Oct 21, 2009 | Zacks Blog: Amylin Loss Narrows | | Oct 21, 2009 | Zacks Blog: Company News for October 21, 2009 | | Oct 21, 2009 | Zacks Blog: Stock Market News for October 21, 2009 |
|
|
Sponsored Links 
0.47